The CDC confirmed the first U.S. case of a new strain of mpox in New York State. The risk to the public is low, and there are no known community cases. Vaccination is recommended for high-risk individuals to prevent the spread of the disease.
Key Points
First U.S. case of mpox clade Ib confirmed in New York State
No known local transmission in New York State currently
JYNNEOS vaccine expected to be effective against the new strain
Pros
Low risk to the public
Vaccination available to prevent the spread
Cons
Mpox can be dangerous for certain groups like immunocompromised individuals, older adults, young children, and pregnant women